1.
Ingrassia J, Maher J, Cline A. A Review of the Risk of Cutaneous Squamous Cell Carcinoma after Vismodegib Therapy. J of Skin [Internet]. 2022Nov.16 [cited 2024Jul.3];6(6):453-7. Available from: https://jofskin.org/index.php/skin/article/view/1762